Brief: Aptose Biosciences Reports Qtrly Loss Per Share $0.12
05/11/2019 22:28
Nov 5 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE THIRD QUARTER ENDED
SEPTEMBER 30,
2019
* QTRLY LOSS PER SHARE $0.12
* TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF
SEPTEMBER
30, 2019 WERE $30.2 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.12 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4D8Mmh
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting